Clinical trial
A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Warfarin in Healthy Male Subjects
NCT01657825 is registered in ClinicalTrials.gov with Astellas Pharma Global Development, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label, Sequential Study of the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Warfarin in Healthy Male Subjects
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- July 31, 2012
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers, pharmacodynamics of warfarin, pharmacokinetics of isavuconazole, pharmacokinetics of s- and r-warfarin